MSVOX Mutual Fund (Vitality Portfolio Class R6) is managed by Morgan Stanley Investment Management. MSVOX expense ratio is 0.90%, holding 33 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2021-12-31.

MSVOX performance shows a YTD return of -0.76%. The 1-year return is 29.48%. MSVOX dividend yield stands at 1.54%, paid annually.

MSVOX top holdings include Argenx Se Spon Adr Each Rep 1 Ord Shs (8.0%), Eli Lilly & Co (7.8%), Ascendis Pharma As Adr (5.5%), Nektar Therapeutics Class A (4.8%), Thermo Fisher (4.3%). View all MSVOX holdings, sector breakdown, or dividend history.

MSVOX can be compared against other funds using the overlap calculator or side-by-side comparison tool. MSVOX alternatives are available via the screener, along with tax-loss harvesting opportunities.